Balance Sheet Deterioration: Petros Pharmaceuticals (PTPI) has transitioned from positive equity of $12.48M in 2023 to negative $7.47M in Q4 2024, with total assets collapsing from $33.8M to $10.6M. Current liabilities ($18.03M) far exceed current assets ($7.29M), yielding a current ratio of 0.40 and a quick ratio of 0.23, signaling severe liquidity strain.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
View 5 tickers daily
Create and manage Watchlists
Import portfolios (no personalized insights)
Chat with the general Sagehood AI Agent
Market Radar: Preview access only
Premium Membership
Unlimited AI-generated insights across all sections
Market Overview
Market Radar (AI-driven investment opportunities)
Access to all Sagehood AI agents, including domain-specific experts
Personalized insights and actionable recommendations for smarter investing